Global economic consequences of selected surgical diseases: A modelling study

The Lancet Global Health

Volumn 3, Issue S2, 2015, Pages S21-S27

  Alkire, Blake C ^a,b   Shrime, Mark G ^a,b,c   Dare, Anna J ^d   Vincent, Jeffrey R ^e   Meara, John G ^b,f  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e DUKE UNIVERSITY   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FINANCIAL MANAGEMENT; FUNDING; GASTROINTESTINAL DISEASE; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH ECONOMICS; HUMAN; INJURY; MATERNAL DISEASE; MATHEMATICAL MODEL; NEOPLASM; NEWBORN DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOCIOECONOMICS; COST OF ILLNESS; DIGESTIVE SYSTEM DISEASES; ECONOMICS; HEALTH; MATERNAL HEALTH SERVICE; METABOLISM; MORTALITY; NEOPLASMS; WOUNDS AND INJURIES;

COST OF ILLNESS; DIGESTIVE SYSTEM DISEASES; GLOBAL HEALTH; GROSS DOMESTIC PRODUCT; HEALTH EXPENDITURES; HUMANS; MATERNAL HEALTH SERVICES; NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; WOUNDS AND INJURIES;

EID: 84929012768     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)70088-4     Document Type: Article

References (36)

1. Debas H, Gosselin R, McCord C, Thind A Surgery. Disease control priorities in developing countries 2006, 1245-1260. Oxford University Press, New York. 2nd edn. D.T. Jamison (Ed.).
2. Shrime MG, Bickler SW, Alkire BC, Mock C Global burden of surgical disease: an estimation from the provider perspective. Lancet Glob Health 2015, 3(S2):S8-S9.
3. Acemoglu D, Johnson S Disease and development: the effect of life expectancy on economic growth 2006, National Bureau of Economic Research, Cambridge, MA, (accessed March 23, 2015). http://www.nber.org/papers/w12269.
4. Bhargava A, Jamison DT, Lau LJ, Murray CJ Modeling the effects of health on economic growth. J Health Econ 2001, 20:423-440.
5. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013, 382:1898-1955.
6. Macroeconomics and health: investing in health for economic development 2001, WHO, World Health Organization, Geneva.
7. Bloom DE, Canning D, Sevilla J The effect of health on economic growth: a production function approach. World Dev 2004, 32:1-13.
8. Bleakley H Disease and development: evidence from hookworm eradication in the American South. Q J Econ 2007, 122:73-117.
9. Jack W, Lewis M Health investments and economic growth: macroeconomic evidence and microeconomic foundations 2008, The World Bank, Washington DC.
10. Jamison DT, Lau LJ, Wang J Heath's contribution to economic growth in an environment of partially endogenous technical progress. Health and economic growth: findings and policy implications 2005, 67-91. The MIT Press, Cambridge. G. Lopez-Casasnovas, B. Rivera, L. Currais (Eds.).
11. Chisholm D, Stanciole AE, Tan Torres Edejer T, Evans DB Economic impact of disease and injury: counting what matters. BMJ 2010, 340:c924.
12. Alkire B, Hughes CD, Nash K, Vincent JR, Meara JG Potential economic benefit of cleft lip and palate repair in sub-Saharan Africa. World J Surg 2011, 35:1194-1201.
13. Alkire BC, Vincent JR, Burns CT, Metzler IS, Farmer PE, Meara JG Obstructed labor and caesarean delivery: the cost and benefit of surgical intervention. PLoS ONE 2012, 7:e34595.
14. Warf BC, Alkire BC, Bhai S, et al. Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa. J Neurosurg Pediatr 2011, 8:509-521.
15. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
16. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
17. Bickler SW, Weiser TG, Kassebaum N, et al. Global burden of surgical conditions. Disease control priorities vol 1 2015, World Bank, Washington, DC. 3rd edn.
18. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet 2012, 380:2063-2066.
19. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases 2011, World Economic Forum, Geneva.
20. Becker GS, Philipson TJ, Soares RR The quantity and quality of life and the evolution of world inequality 2003, National Bureau of Economic Research, Cambridge, MA, (accessed March 23, 2015). http://www.nber.org/papers/w9765.
21. John R, Ross H The global economic cost of cancer: a report summary 2010, American Cancer Society, Atlanta.
22. The health of nations: the value of a statistical life 2008, Government of Australia, Government of Australia, Canberra.
23. Open data (world development indicators) World Bank, (accessed Oct 15, 2014). http://data.worldbank.org/.
24. Hammitt JK, Robinson LA The income elasticity of the value per statistical life: transferring estimates between high and low income populations. J Benefit Cost Anal 2011, published online Jan 3. http://dx.doi.org/10.2202/2152-2812.1009.
25. Frequently asked questions on mortality risk valuation Environmental Protection Agency, (accessed Oct 15, 2013). http://yosemite.epa.gov/ee/epa/eed.nsf/webpages/mortalityriskvaluation.html.
26. Lindhjem H, Braathen NA Mortality risk valuation in environment, health and transport policies 2012, OECD, Paris.
27. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 1 (accessed Oct 17, 2014). http://globocan.iarc.fr.
28. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384:980-1004.
29. Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384:957-979.
30. Cancer control opportunities in low- and middle-income countries 2007, Institute of Medicine Committee on Cancer Control in Low- and Middle-Income Countries, National Academies Press, Washington, DC.
31. Chao TE, Sharma K, Mandigo M, et al. Cost-effectiveness of surgery and its policy implications for global health: a systematic review and analysis. Lancet Glob Health 2014, 2:e334-e345.
32. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007, 370:1929-1938.
33. Abegunde D, Stanicole A An estimation of the economic impact of chronic noncommunicable diseases in selected countries 2006, World Health Organization, Geneva.
34. Grimes CE, Henry JA, Maraka J, Mkandawire NC, Cotton M Cost-effectiveness of surgery in low- and middle-income countries: a systematic review. World J Surg 2014, 38:252-263.
35. Evans D, Torres Edejer T, Chisholm D, Stanciole A WHO guide to identifying the economic consequences of disease and injury 2009, World Health Organization, Geneva.
36. Hammit JK QALYs versus WTP. Risk Anal 2002, 22:985-1001.